Welcome to the Lab Report, a monthly news briefing designed to highlight recent news in the clinical laboratory industry. As champions for clinical labs, we want to spread news about the great work being done in healthcare facilities and clinical settings throughout the United States.
Check back often to find out about award winners, staff and manager promotions, facility expansions, policy and regulatory updates, association news and more. We hope you will share this content with your fellow MLPs, managers and friends.
To help us continue to spread news about the lab, keep our team updated by emailing press releases, photos and short articles to us using the Contact Us tools on this site.
Sysmex Named on Most Innovative Companies List
Sysmex recently announced that it is ranked 28th on Forbes’ 2016 list of the World’s Most Innovative Companies. The Forbes list identified 100 global companies that are the most innovative and projected to continue or increase their innovation in the future. The Forbes list is compiled using an internationally recognized innovation formula that factors equity, current sales and expected growth. Companies are ranked by their innovation premium and the educated opinion of equity investors that the company will continue to create profitable new growth.
Sysmex develops, manufactures and sells clinical laboratory instruments, reagents and software used for in vitro diagnostics. With the increased emphasis on early detection and preventive medicine, Sysmex plays a prominent role in shaping the future of healthcare through in vitro diagnostics. The company’s hematology (blood) analyzers offer an expanded offering of parameters to aid in the detection of conditions, such as anemia, thrombocytopenia and infection/inflammation.
Martignetti Named to Expand Important Cancer Research at WCHN
Western Connecticut Health Network (WCHN) has named internationally known physician-scientist, John A. Martignetti, MD, PhD, an expert in human genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, as the network director of the laboratory for translational research at the WCHN Biomedical Research Institute. Under this collaboration, Martignetti’s well-established bedside to bench cancer research methodology will be extended to patients at Danbury, Norwalk and New Milford hospitals. He will work closely with the oncology physicians and research scientists across WCHN to build on their nationally recognized efforts.
Working alongside new colleagues at WCHN, Martignetti will continue to explore precision medicine strategies in order to: 1) advance the care and treatment of patients with gynecologic cancer and 2) establish effective biomarkers to enable reliable disease surveillance leading to more predictable care pathways. He will also pursue development of novel therapeutics while studying the genetics of hereditary ovarian and breast cancer.
ERBA Diagnostics Appoints Hayden Jeffreys as interim CEO
ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, recently announce that, effective as of January 1, 2017, Hayden Jeffreys will become the Interim Chief Executive Officer. Jeffreys’ appointment as Interim CEO is subject to Mr. Jeffreys having obtained the nonimmigrant visa necessary for him to work in the United States of America. He has served as a director on the Board of Directors since May 31, 2016, and he plans to continue serving in that role.
Jeffreys has 20 years of experience in the clinical diagnostics industry, with specialization in the molecular diagnostic and blood bank fields. He also serves as the commercial director for the molecular diagnostics division and vice president business development and strategy for ERBA Diagnostics Mannheim GmbH, and he plans to continue serving in that role too. Additionally, he does not receive compensation from the Company for his service as a director on the Board and he is not expected to receive compensation from the Company for serving as Interim Chief Executive Officer.
Thermo Fisher Scientific Wins R&D 100 Award
Thermo Fisher Scientific, Inc. recently announced that the R&D 100 Awards Committee has selected the Thermo Scientific Vanquish Flex UHPLC system instruments among R&D Magazine’s 100 Most Innovative Products of 2016. Known as the “Oscars of Innovation,” the R&D 100 Awards recognize the year’s most significant technology advances across industry, academia and government-sponsored research.
The Thermo Scientific Vanquish Flex UHPLC system is an ultra-high performance liquid chromatography (UHPLC) system with the flexibility required for labs developing methods ranging from high-throughput analyses to pharmaceutical quality control applications. The fully bioinert system is designed for high speed, resolution and sensitivity—allowing researchers who perform biopharmaceutical analyses to obtain high-quality and consistent data.
New PCS Software to Improve Pipette Calibration Workflow
Liquid handling quality assurance company Artel recently announced the release of the PCS Software. The software will also be integrated with the latest generation of the Pipette Calibration System (PCS), to be available early 2017. The new software was developed in order to provide a fully integrated solution that allows testing of all elements important to pipetting, including the operator’s technique, the pipette performance and the pipette tip.
The new software helps labs streamline their staff’s pipetting tasks in multiple ways. The user interface offers intuitive dashboards that track the calibration status of the full pipette inventory, as well as performance assessments of all operators. It enables management to review and approve results from anywhere in the organization, keeping track of pipettes and operator performance.
Innovative Telepathology Lab ‘Goes Live’ in Rwanda
Jean Baptiste Mazarati, PhD, head of the Rwanda Biomedical Center/National Reference Laboratory, representing the Rwandan Ministry of Health and the Honorable Minister Diane Gashumba, announced the official “go live” of an innovative telepathology laboratory in Butaro, Rwanda. The laboratory—an initiative of Partners for Cancer Diagnosis and Treatment in Africa—is providing patients in resource-limited areas of Rwanda with access to rapid cancer diagnostics and appropriate care and treatment.
The telepathology lab is further enhanced by the simultaneous installation of a fully automated tissue processing system, which has transformed the capacity of the laboratory towards 1000 blocks per day and allows for same day turnaround on biopsies. A team of ASCP volunteer pathologists in the United States will use the telepathology equipment to perform rapid diagnostics and review patient specimens for therapy in conjunction with the one pathologist currently stationed in Butaro.